BIO vs BLFY · rev $651.0M vs $274.9M cap
BIO (BIO) versus Blue Foundry Bancorp (BLFY) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Blue Foundry Bancorp (BLFY) is a banks - regional company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
BLFY does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. BLFY currently screens at market cap $274.9M.
Not investment advice. Open the BIO and BLFY stock pages for the full models.
Not investment advice.